JPMorgan Chase & Co. (CMC.F)
| Previous close | 179.60 |
| Open | 180.00 |
| Bid | 180.94 x 80000 |
| Ask | 181.06 x 80000 |
| Day's range | 179.50 - 181.28 |
| 52-week range | 126.50 - 190.18 |
| Volume | |
| Avg. volume | 1,634 |
| Market cap | 520.576B |
| Beta (5Y monthly) | 1.11 |
| PE ratio (TTM) | 11.75 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 4.23 (2.33%) |
| Ex-dividend date | 05 Jul 2024 |
| 1y target est | N/A |
- Business Wire
JPMorgan Chase Declares Preferred Stock Dividends
NEW YORK, June 14, 2024--JPMorgan Chase & Co. (NYSE: JPM) ("JPMorgan Chase" or the "Firm") has declared dividends on the outstanding shares of the Firm’s Series CC, FF and HH preferred stock. Information can be found on the Firm’s Investor Relations website at https://www.jpmorganchase.com/ir/news.
- PR Newswire
J.P. Morgan Life Sciences Private Capital Closes Inaugural Biotechnology Venture Capital Fund with over $500 million in Commitments
J.P. Morgan Private Capital, a venture capital and growth equity investment team within J.P. Morgan Asset Management, today announced the final close of the first Life Sciences Private Capital offering, 270 Life Sciences Private Capital Fund I (the "Fund"), led by Chief Investment Officer Stephen Squinto, Ph.D. and Managing Partner Gaurav Gupta, M.D., M.S.E. The fund closed above its $500 million target, attracting strong support from investors, including institutional allocators, strategic corp
- Business Wire
JPMorgan Chase to Host Second-Quarter 2024 Earnings Call
NEW YORK, June 11, 2024--As previously announced, JPMorgan Chase & Co. (NYSE: JPM) ("JPMorgan Chase" or the "Firm") will host a conference call to review second-quarter 2024 financial results on Friday, July 12, 2024 at 8:30 a.m. (EDT). The results are scheduled to be released at approximately 7:00 a.m. (EDT). The live audio webcast and presentation slides will be available on www.jpmorganchase.com under Investor Relations, Events & Presentations.
